特斯拉Q3在華收入同比增64.8%
特斯拉(TSLA.O)提交10-Q文件,披露公司在全球主要市場的營收數據。文件顯示,特斯拉(TSLA.O)第三季度總營收同比增長56%至214.54億美元,其中中國市場營收達51.31億美元,上年同期31.13億美元,同比增長64.8%,中國市場仍爲特斯拉第二大市場,佔公司總營收比例爲23.9%;美國市場營收102.36億美元,上年同期64.14億美元。
特斯拉在財報中表示,公司降低成本的努力和額外的本地化採購和製造是汽車可負擔性的關鍵,使其在中國的車輛價格具有競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.